Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.

Saved in:
Bibliographic Details
Title: Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.
Authors: Marino M; Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.; Oncological Endocrinology Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy., Rosset F; Dermatology Department, San Lazzaro Hospital, University of Turin, 10126 Turin, Italy., Nervo A; Oncological Endocrinology Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy., Piovesan A; Oncological Endocrinology Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy., Pala V; Dermatology Department, San Lazzaro Hospital, University of Turin, 10126 Turin, Italy., Vaccaro E; Oncological Endocrinology Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy., Mastorino L; Dermatology Department, San Lazzaro Hospital, University of Turin, 10126 Turin, Italy., Calogero AE; Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy., Arvat E; Oncological Endocrinology Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy.
Source: Biomedicines [Biomedicines] 2025 Dec 11; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2227-9059
DOI:10.3390/biomedicines13123044